Search

everythinglearnresearchcommunity

for

Search:↓

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

An imbalanced gut and lack of biotin can cause hair loss in mice.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Targeting the skin's endocannabinoid system could help treat skin disorders.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Peptide-based hydrogels are promising for healing chronic wounds effectively.

The Hedgehog signaling pathway is important for skin and hair growth and can lead to cancer if it doesn't work right.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.